Breaking newsResearchCOVID-19
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication